Pacific Biosciences
PACB
PACB
129 hedge funds and large institutions have $487M invested in Pacific Biosciences in 2016 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
11% less call options, than puts
Call options by funds: $5.45M | Put options by funds: $6.16M
29% less capital invested
Capital invested by funds: $686M → $487M (-$199M)
Holders
129
Holding in Top 10
4
Calls
$5.45M
Puts
$6.16M
Top Buyers
| 1 | +$25.9M | |
| 2 | +$16.5M | |
| 3 | +$8.07M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.95M |
| 5 |
TA
Teachers Advisors
New York
|
+$4.2M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$8.34M | |
| 3 | -$3.38M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$2.77M |
| 5 |
Morgan Stanley
New York
|
-$2.42M |